Symet Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Miyapur,Hyderabad - 72., Andhra Pradesh, India, established in 1999.
1999 Miyapur,Hyderabad - 72., Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Symet Drugs Private Limited

Symet Drugs Private Limited, a struck off private limited company, was established on 09 July 1999 in Miyapur,Hyderabad - 72., Andhra Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231AP1999PTC032066. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.56 M.

Its leadership includes Raja Rao Nannamuri (Director), Ravi Shankar Jasti (Director), Srinivasa Rao Nannamuri (Director). Its latest AGM occurred on 29 September 2008, with the balance sheet filed on 31 March 2008. It is based at F No. 102Sri Kalyani K B R Complex Block No.3, S No. 216, Miyapur,Hyderabad - 72., Andhra Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231AP1999PTC032066

  • Registration Number

    032066

  • Incorporation Date

    09 July 1999

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.56 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.56 M
  • Company Age 26 Year, 7 Months
  • Last Filing with ROC 31 Mar 2008
Company report

Symet Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Symet Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Symet Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Raja Rao Nannamuri Director 09 Jan 2006 Current
Ravi Shankar Jasti Director 09 Jul 1999 Current
Srinivasa Rao Nannamuri Director 09 Jul 1999 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Symet Drugs.

Enhance accessibility to Symet Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Symet Drugs revenue growth over time
Symet Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Symet Drugs?

Unlock access to Symet Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Symet Drugs?

Unlock and access historical data on people associated with Symet Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Symet Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symet Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Symet Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Symet Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2008 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Symet Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Vijayawada. was documented.

  • Director Appointment

    Raja Rao Nannamuri was appointed as a Director was appointed as a Director on 09 Jan 2006 & has been associated with this company since 20 years 1 month . was recorded as a recent event.

  • Director Appointment

    Ravi Shankar Jasti was appointed as a Director was appointed as a Director on 09 Jul 1999 & has been associated with this company since 26 years 7 months . was recorded as a recent event.

  • Director Appointment

    Srinivasa Rao Nannamuri was appointed as a Director was appointed as a Director on 09 Jul 1999 & has been associated with this company since 26 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Symet Drugs Private Limited was registered on 09 Jul 1999 with Roc Vijayawada & aged 26 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Symet Drugs Private Limited?

The CIN of Symet Drugs Private Limited is U24231AP1999PTC032066.

Where is Symet Drugs Private Limited headquartered?

Symet Drugs Private Limited is headquartered at F No. 102Sri Kalyani K B R Complex Block No.3, S No. 216, Miyapur,Hyderabad - 72., Andhra Pradesh.

When was Symet Drugs Private Limited incorporated?

Symet Drugs Private Limited was incorporated on 09 July 1999.

Who are the current directors of Symet Drugs Private Limited?

The current directors of Symet Drugs Private Limited are

What is the primary industry of Symet Drugs Private Limited?

The primary industry of Symet Drugs Private Limited is Chemicals.

Is Symet Drugs Private Limited a listed company?

Symet Drugs Private Limited is unlisted.

What is the capital structure of Symet Drugs Private Limited?

The authorized capital of Symet Drugs Private Limited is ₹2.50 M, and the paid-up capital is ₹0.56 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available